Voya Financial Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$526K Sell
7,534
-388
-5% -$27.1K 0.05% 149
2025
Q1
$585K Sell
7,922
-249
-3% -$18.4K 0.06% 128
2024
Q4
$536K Sell
8,171
-2,516
-24% -$165K 0.06% 147
2024
Q3
$830K Sell
10,687
-1,172
-10% -$91K 0.09% 105
2024
Q2
$927K Sell
11,859
-164
-1% -$12.8K 0.1% 91
2024
Q1
$821K Buy
12,023
+127
+1% +$8.67K 0.09% 102
2023
Q4
$801K Buy
11,896
+171
+1% +$11.5K 0.1% 100
2023
Q3
$791K Sell
11,725
-452
-4% -$30.5K 0.1% 91
2023
Q2
$863K Buy
12,177
+45
+0.4% +$3.19K 0.1% 84
2023
Q1
$840K Buy
12,132
+428
+4% +$29.6K 0.1% 88
2022
Q4
$797K Buy
11,704
+1,469
+14% +$100K 0.1% 100
2022
Q3
$562K Buy
10,235
+466
+5% +$25.6K 0.07% 128
2022
Q2
$655K Buy
9,769
+1,776
+22% +$119K 0.08% 112
2022
Q1
$536K Buy
7,993
+3,292
+70% +$221K 0.06% 152
2021
Q4
$275K Buy
+4,701
New +$275K 0.03% 227
2021
Q2
Sell
-8,251
Closed -$412K 277
2021
Q1
$412K Sell
8,251
-7,433
-47% -$371K 0.02% 470
2020
Q4
$787K Sell
15,684
-988
-6% -$49.6K 0.03% 309
2020
Q3
$919K Buy
16,672
+4,277
+35% +$236K 0.05% 264
2020
Q2
$656K Buy
12,395
+153
+1% +$8.1K 0.03% 311
2020
Q1
$545K Buy
12,242
+4,056
+50% +$181K 0.03% 323
2019
Q4
$409K Buy
8,186
+676
+9% +$33.8K 0.02% 437
2019
Q3
$340K Buy
7,510
+265
+4% +$12K 0.02% 459
2019
Q2
$297K Buy
7,245
+59
+0.8% +$2.42K 0.02% 493
2019
Q1
$309K Sell
7,186
-10,680
-60% -$459K 0.02% 475
2018
Q4
$675K Sell
17,866
-1,337
-7% -$50.5K 0.05% 258
2018
Q3
$763K Sell
19,203
-12,182
-39% -$484K 0.04% 275
2018
Q2
$1.1M Sell
31,385
-6,948
-18% -$242K 0.07% 211
2018
Q1
$1.35M Buy
38,333
+978
+3% +$34.4K 0.09% 191
2017
Q4
$1.27M Buy
37,355
+7,334
+24% +$250K 0.08% 204
2017
Q3
$1.01M Buy
30,021
+8,453
+39% +$283K 0.07% 226
2017
Q2
$736K Buy
21,568
+3,172
+17% +$108K 0.05% 250
2017
Q1
$576K Buy
18,396
+7,346
+66% +$230K 0.04% 266
2016
Q4
$302K Buy
11,050
+3,181
+40% +$86.9K 0.03% 358
2016
Q3
$260K Buy
+7,869
New +$260K 0.03% 356